Organization of gynaecological cancer care最新文献

{"title":"651 Perioperative anaemia and its perils","authors":"S. Patel, S. John, G. Pactat, S. Saso, S. Thakrar","doi":"10.1136/ijgc-2021-esgo.311","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.311","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123569876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"596 Clinicians’ views on endometrial cancer follow-up strategies","authors":"A. Amirthanayagam, E. Jones, E. Moss","doi":"10.1136/ijgc-2021-esgo.309","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.309","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130612572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"474 ERAS protocols in gynaecological oncology. Should we include thoracic epidural analgesia?","authors":"A. Pandraklakis, A. Prodromidou, T. Lappas, E. Stamatakis, D. Valsamidis, D. Haidopoulos, A. Rodolakis, N. Thomakos","doi":"10.1136/ijgc-2021-esgo.305","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.305","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127956071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"380 Chemotherapy and sars-cov2 infection: a single center experience","authors":"R. Cioffi, G. Sabetta, F. Galli, C. Saponaro, E. Rabaiotti, L. Bocciolone, M. Petrone, G. Candotti, G. Mangili, A. Bergamini","doi":"10.1136/ijgc-2021-esgo.301","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.301","url":null,"abstract":"Introduction/Background*During COVID-19 pandemic many studies have been published;concerning oncological patients SARS-CoV2 infection is correlated to a 29.4% mortality rate. Few data describe the incidence and outcome of COVID-19 infection in patients undergoing chemotherapy.The aim of our study is to assess COVID-19 behavior in patients treated with chemotherapy.MethodologyWe considered 179 patients affected by gynecological cancers who underwent chemotherapy during the pandemic. Patients were educated to respect COVID-19 rules of conduct. We used different criteria to screen the patients with the rhino-pharyngeal swab and anamnestic questionnaire, so we analyzed two different periods: 11th March–15th October 2020, 16th October 2020–30th April 2021. From 11th March to 30th April 2020 we screened the symptomatic patients;from 1st May to 15th October 2020 the swab was made to all patients before their first access. Conversely, during the second period (16th October 2020-30th April 2021), we made the swab to all patients every 28 days. Patients resulted positive to COVID-19 were suspended from chemotherapy until their first negative swab.Result(s)*During the first period 806 chemotherapy cycles were carried out: there were no positive patients. During the second period 775 chemotherapy cycles were carried out: 13/99 (13.3%) patients resulted positive. Three of them (23.1%) were symptomatic;among these only one patient (7.7%) had SARS-CoV2 pneumonia and was admitted to semi-intensive care;what is important to underline is that this patient was positive before starting the second line chemotherapy. Two patients (15.4%) were paucisymptomatic, one of whom died for cancer progression. Overall, 10 patients (77%) resulted asymptomatic.Conclusion*Our experience supports that chemotherapy does not worsen SARS-CoV2 symptoms and mortality rate. Only with periodic swabs it was possible to identify positive patients, as they were asymptomatic. Moreover, none of the patients who became positive during chemotherapy developed pneumonia.Further studies are needed to evaluate the protective role of chemotherapy against COVID-19 symptoms and complications.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128956810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"446 Impact of COVID-19 pandemic on gynaecological oncology healthcare in the Netherlands: data from the prospective dutch gynaecological oncology audit","authors":"M. Algera, W. van Driel, B. Slangen, M. Wouters, R. Kruitwagen","doi":"10.1136/ijgc-2021-esgo.303","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.303","url":null,"abstract":"Introduction/Background ∗ The COVID-19 pandemic caused drastic healthcare changes worldwide. To date, the impact of these pandemic-induced alterations in gynaecological oncology healthcare is unknown. We assessed the impact of the COVID-19 pandemic on gynaecological oncology healthcare in the Netherlands by analysing data of the Dutch Gynaecological Oncology Audit (DGOA). Methodology All patients in The Netherlands undergoing surgery for ovarian, vulvar, endometrial or cervical cancer are registered in the DGOA since 2014. To evaluate whether the COVID-19 pandemic influenced care, we compared the following parameters that are available in the DGOA: surgical volume, time to first treatment (TTFT), length of hospital stay (LOHS), postoperative complications and 30-day mortality. Four periods were identified in 2020 based on incidence of COVID-19 infections in The Netherlands: 'Pre-COVID-19', 'First wave', 'Interim period' and 'Second wave'. Using descriptive statistics, results from 2020 were compared with the same four periods of 2018-2019 combined. Result(s)∗ A total of 12.447 surgical procedures were analysed. Analysing the four periods in 2020, compared to the average volumes of 2018-2019, the surgical volume for the four tumour types decreased during the first COVID-19 wave and interim period (figure 1). This was due to a decrease in surgical volume for cervical cancer only (17.2% in 2020), while volumes for ovarian, vulvar and endometrial cancer remaining stable. Moreover, during the interim period, only 51% of the expected cervical cancer procedures were performed. A significantly shorter median TTFT was observed in all four malignancies in 2020, compared to 2018-2019 (table 1). No differences in LOHS, postoperative complications and 30-day mortality were observed (table 1). Conclusion∗ The COVID-19 pandemic clearly impacted gynaecological oncology healthcare in The Netherlands. During the first COVID-19 wave, surgical volume for gynaecological oncological procedures dropped considerably, mainly due to a substantial drop in surgical volume for cervical cancer. This is probably caused by the temporary interruption of the population screening program. During the COVID-19 pandemic, waiting time to start therapy was shorter. The quality of perioperative healthcare was not negatively impacted by the pandemic.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"152 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124247921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"338 Same day discharge in minimally invasive surgery for gynaecological cancer","authors":"C. Hickish, J. Dilley, S. Abdi, S. Phadnis, E. Brockbank","doi":"10.1136/ijgc-2021-esgo.300","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.300","url":null,"abstract":"Introduction/Background*Same-day discharge (SDD) has been found to be safe and attainable following minimally invasive surgery (MIS) for gynaecological cancer.1 We audited the compliance to SDD, opposed to 24 hours discharge, at the Royal London Hospital.MethodologyWe performed a retrospective audit of all minimally invasive hysterectomies performed at the Royal London Hospital in 2019 and 2020. All patients were identified for SDD at pre-op clinic and were followed up until 30 days post discharge.Data was collected from electronic patient to record demographic, operating time & outcome, postoperative recovery (+/- complication and readmission) and time of discharge.Following the first audit cycle in 2019, interventions were performed comprising of staff education to highlight the human factors that led to failed SDD (including delayed prescriptions, discharge summaries and removal of catheters).Result(s)*A total of 12 patients were selected for SDD in 2020 compared to 22 in 2019 with 30 day follow up for all patients. Numbers of patient in 2020 was reduced due to covid. Successful SDD was achieved in 42% of cases in 2020 compared to 56% in 2019. Of those planned for SDD, 50% of those that failed were due to unavoidable intraoperative complications. No SDD discharges in 2020 failed due to pharmacy, transport or discharge documentation delays (7 failed SDD in 2019 due to these factors). No re-admissions or complications were recorded.Conclusion*Same day discharge continues to be safe and achievable following minimally invasive surgery for gynecological cancer, despite disruption from the Covid-19 pandemic. Auditing and implementation of interventions helps improve this pathway.ReferenceKorsholm M, Mogensen O, Jeppesen MM, Lysdal VK, Traen K, Jensen PT. Systematic review of same-day discharge after minimally invasive hysterectomy. Int J Gynaecol Obstet 2017 Feb;136(2):128–137. doi: 10.1002/ijgo.12023. Epub 2016 Nov 11. PMID: 28099736.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128235523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"293 Quality of training in cervical cancer surgery: a survey from the European network of young gynaecologic oncologists (ENYGO)","authors":"N. Bizzarri, A. Pletnev, Z. Razumova, K. Zalewski, C. Theofanakis, I. Selcuk, T. Nikolova, M. Lanner, N. Gómez-Hidalgo, J. Kacperczyk-Bartnik, D. Querleu, D. Cibula, R. Verheijen, A. Fagotti","doi":"10.1136/ijgc-2021-esgo.298","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.298","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"184 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123722696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"1056 Live surgical broadcast and patient outcome – 10 years of experience from the international Charité MAYO conferences 2010–2019","authors":"J. Altmann, R. Chekerov, C. Fotopoulou, A. du Bois, W. Cliby, S. Dowdy, K. Podratz, W. Lichtenegger, O. Camara, R. Tunn, D. Cibula, S. Kümmel, I. Vergote, S. Chopra, M. Biebl, V. Chiantera, J. Neymeyer, Z. Muallem, Ju Blohmer, J. Sehouli","doi":"10.1136/ijgc-2021-esgo.327","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.327","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"97 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124518301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"313 COVID-19 vaccination prior to gynaecological oncology surgery : vaccine compliance and peri-operative outcomes in a tertiary cancer institute in India","authors":"R. Modi, G. Pandey, S. Chauhan, S. Saini, M. Gupta, S. Verma","doi":"10.1136/ijgc-2021-esgo.299","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.299","url":null,"abstract":"Introduction/Background India experienced a deadly second wave of COVID-19 pandemic starting mid-February 2021 with test positivity rate of 25-45 % suggesting high community transmission. Indian COVID-19 vaccination program for 60 years + and above 45 years with co-morbidities began on 1st March 2021. As per COVIDsurg collaborative data, between 0.6% and 1.6% of patients develop COVID-19 infection after elective surgery. Even after use of mitigation measures like pre-surgery RT/PCR and COVID free surgical pathways, COVID-19 is a significant nosocomial infection with 4- and 8-fold increased risk of death in the 30 days following surgery. Our aim was to study vaccine compliance in patients counselled to be vaccinated before surgery, pre-surgery RT/PCR positivity rate, 30-day post-operative SARS Cov-2 rate and peri-operative outcomes. Methodology In this prospective observational study, patients waitlisted for major gynaecological cancer surgeries who were also eligible for COVID-19 vaccination were enrolled. Patients were counselled to get atleast one dose vaccinated 2 weeks before elective surgery. In cases of neo-adjuvant chemotherapy, vaccination was advised atleast 2 weeks after the last dose of chemotherapy. Patients vaccinated with atleast 1 dose - 2 weeks prior to surgery or those with both doses vaccinated atleast a week prior to surgery were eligible for study. Mitigation measures of negative pre-surgery RT/PCR (within 24 hours prior to surgery) and COVID free surgical pathway were used. Result(s) In the overall cohort of 53 patients, 34 got vaccinated suggesting compliance of 64%. In the unvaccinated cohort, 52.6% were pře-surgery RT/PCR +ve against 5.8% vaccinated patients (p = 0.0001). Thirty- day post-operative SARS Cov-2 rate was 44.4% and 0% in the unvaccinated and vaccinated cohort respectively (p = 0.0001). No cases of severe COVID-19 requiring hospitalisation were seen in the vaccinated cohort. There was no 30-day post-operative mortality in either cohorts. Conclusion Counselling regarding COVID-19 vaccination prior to surgery should be an essential part of pre-operative work up. COVID-19 vaccination prior to surgery has two-fold advantage. It prevents the postponement of elective cancer surgeries which are time bound. There is a significant decreased risk of severe COVID-19 infection and related morbidity post-operatively in the vaccinated population. (Figure Presented).","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"48 75","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120970096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"726 Applicability of pre-operative patient reported duke activity scale index in prediction of postoperative complications in gynaecological oncology","authors":"L. Sevinyan, A. Tailor, P. Prabhu, P. Williams, Thumuluru Kavitha Madhuri","doi":"10.1136/ijgc-2021-esgo.316","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.316","url":null,"abstract":"","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130475898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}